跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SCENESSE - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
SCENESSE
Authorized
STANDARD
SCENESSE
CLINUVEL, INC.
🇨🇦 Health Canada
Approval Date
Aug 7, 2026
Approval ID
da6a1c2b543f1b50
Company
CLINUVEL, INC.
Type
Standard
Approval Details
Approval Id
da6a1c2b543f1b50
Drug Approval Canada Name
SCENESSE
Product Name
SCENESSE
Status
Approved
Status Date
2026-07-09
Drug Class
Human
Dosage Form
Implant
Route Of Administration
Subcutaneous
Schedule
PRESCRIPTION RECOMMENDED
Atc Original
D02BB02 AFAMELANOTIDE
Aig Number
0168474001
Company Name
CLINUVEL, INC.
Company Address
1350 Old Bayshore Hwy., Suite 520 Burlingame California United States 94010
Company Detail Path
/organization/clinuvel-inc
Company Information
Pharmaceutical Company Name
CLINUVEL, INC.
Country Name
United States
Province Name
California
City Name
san mateo,california,country_us
Address
1825 S Grant St Ste 200
Active Ingredients
AFAMELANOTIDE (AFAMELANOTIDE ACETATE)
16 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Aug 7, 2026
Approval ID
da6a1c2b543f1b50
Type
Standard
Back to Health Canada Approvals